A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses

Journal of Visualized Experiments

Volumn , Issue 90, 2014, Pages

  Claiborne, Daniel T ^a   Prince, Jessica L ^a   Hunter, Eric ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CEM; Gag; GXR25; HIV 1; Infectious diseases; Issue 90; MJ4; Replication capacity; Viral fitness; Viral replication

Indexed keywords

EID: 84906875109     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51506     Document Type: Article

References (48)

1. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., & Oldstone, M. B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of virology. 68, 6103-6110 (1994).
2. Koup, R. A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of virology. 68, 4650-4655 (1994).
3. Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. The Journal of experimental medicine. 189, 991-998 (1999).
4. Schmitz, J. E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283, 857-860 (1999).
5. Brumme, Z. L. et al. Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. Journal of virology. 82, 9216-9227, doi:JVI.01041-08 [pii]10.1128/JVI.01041-08 (2008).
6. Leslie, A. J. et al. HIV evolution: CTL escape mutation and reversion after transmission. Nature medicine. 10, 282-289, doi:10.1038/nm992nm992 [pii] (2004).
7. Phillips, R. E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354, 453-459, doi:10.1038/354453a0 (1991).
8. Price, D. A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proceedings of the National Academy of Sciences of the United States of America. 94, 1890-1895 (1997).
9. Goulder, P. J. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature medicine. 3, 212-217 (1997).
10. Tang, J. et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. Journal of virology. 76, 8276-8284 (2002).
11. Prentice, H. A. et al. HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race? Journal of virology. 87, 4043-4051, doi:10.1128/JVI.03302-12 (2013).
12. Migueles, S. A. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proceedings of the National Academy of Sciences of the United States of America. 97, 2709-2714, doi:10.1073/pnas.050567397050567397 [pii] (2000).
13. Leslie, A. et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. Journal of virology. 84, 9879-9888, doi:10.1128/JVI.00320-10 (2010).
14. Kaslow, R. A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature medicine. 2, 405-411 (1996).
15. Altfeld, M. et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS. 17, 2581-2591, doi:10.1097/01.aids.0000096870.36052.b6 (2003).
16. Kiepiela, P. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nature medicine. 13, 46-53, doi:nm1520 [pii]10.1038/nm1520 (2007).
17. Mothe, B. et al. Definition of the viral targets of protective HIV-1-specific T cell responses. Journal of translational medicine. 9, 208, doi:10.1186/1479-5876-9-208 (2011).
18. Peyerl, F. W., Barouch, D. H., & Letvin, N. L. Structural constraints on viral escape from HIV-and SIV-specific cytotoxic T-lymphocytes. Viral immunology. 17, 144-151, doi:10.1089/0882824041310658 (2004).
19. Rolland, M. et al. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PloS one. 3, e1424, doi:10.1371/journal.pone.0001424 (2008).
20. Wagner, R. et al. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. J Immunol. 162, 3727-3734 (1999).
21. Wang, Y. E. et al. Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. Journal of virology. 83, 1845-1855, doi:10.1128/JVI.01061-08 (2009).
22. Chopera, D. R. et al. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS pathogens. 4, e1000033, doi:10.1371/journal.ppat.1000033 (2008).
23. Crawford, H. et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. The Journal of experimental medicine. 206, 909-921, doi:10.1084/jem.20081984 (2009).
24. Boutwell, C. L. et al. Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins. Journal of virology. 87, 3952-3965, doi:10.1128/JVI.03233-12 (2013).
25. Brockman, M. A. et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. Journal of virology. 81, 12608-12618, doi:10.1128/JVI.01369-07 (2007).
26. Crawford, H. et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. Journal of virology. 81, 8346-8351, doi:JVI.00465-07 [pii]10.1128/JVI.00465-07 (2007).
27. Martinez-Picado, J. et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. Journal of virology. 80, 3617-3623, doi:80/7/3617 [pii]10.1128/JVI.80.7.3617-3623.2006 (2006).
28. Schneidewind, A. et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Journal of virology. 81, 12382-12393, doi:JVI.01543-07 [pii]10.1128/JVI.01543-07 (2007).
29. Wright, J. K. et al. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity. Journal of virology. 86, 3193-3199, doi:10.1128/JVI.06682-11 (2012).
30. Kawashima, Y. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature. 458, 641-645, doi:nature07746 [pii]10.1038/nature07746 (2009).
31. Goepfert, P. A. et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. The Journal of experimental medicine. 205, 1009-1017, doi:jem.20072457 [pii]10.1084/jem.20072457 (2008).
32. Brockman, M. A. et al. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. Journal of virology. 84, 11937-11949, doi:10.1128/JVI.01086-10 (2010).
33. Huang, K. H. et al. Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations. PloS one. 6, e19018, doi:10.1371/journal.pone.0019018 (2011).
34. Wright, J. K. et al. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. Journal of virology. 84, 10820-10831, doi:10.1128/JVI.01084-10 (2010).
35. Wright, J. K. et al. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. Journal of virology. 85, 3996-4006, doi:10.1128/JVI.02520-10 (2011).
36. Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. Journal of virology. 59, 284-291 (1986).
37. Brockman, M. A., Tanzi, G. O., Walker, B. D., & Allen, T. M. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4-and CCR5-tropic HIV-1 by flow cytometry. Journal of virological methods. 131, 134-142, doi:10.1016/j.jviromet.2005.08.003 (2006).
38. Ndung'U, T., Renjifo, B., & Essex, M. Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone. Journal of virology. 75, 4964-4972, doi:10.1128/JVI.75.11.4964-4972.2001 (2001).
39. Prince, J. L. et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS pathogens. 8, e1003041, doi:10.1371/journal.ppat.1003041 (2012).
40. Ostrowski, M. A., Chun, T. W., Cheseboro, B., Stanley, S. K., & Tremblay, M. Detection assays for HIV proteins. Current protocols in immunology/edited by John E. Coligan. Chapter 12, Unit 12 15, doi:10.1002/0471142735.im1205s70 (2006).
41. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., & Pease, L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77, 61-68 (1989).
42. Inoue, H., Nojima, H., & Okayama, H. High efficiency transformation of Escherichia coli with plasmids. Gene. 96, 23-28 (1990).
43. Bichara, M., Pinet, I., Schumacher, S., & Fuchs, R. P. Mechanisms of dinucleotide repeat instability in Escherichia coli. Genetics. 154, 533-542 (2000).
44. Ackerson, B., Rey, O., Canon, J., & Krogstad, P. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. Journal of virology. 72, 303-308 (1998).
45. Dudley, D. M. et al. A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates. BioTechniques. 46, 458-467, doi:10.2144/000113119 (2009).
46. Ganser-Pornillos, B. K., von Schwedler, U. K., Stray, K. M., Aiken, C., & Sundquist, W. I. Assembly properties of the human immunodeficiency virus type 1 CA protein. Journal of virology. 78, 2545-2552 (2004).
47. Forshey, B. M., von Schwedler, U., Sundquist, W. I., & Aiken, C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. Journal of virology. 76, 5667-5677 (2002).
48. Gottlinger, H. G., Dorfman, T., Sodroski, J. G., & Haseltine, W. A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences of the United States of America. 88, 3195-3199 (1991).